Buprenorphine dose self-selection: Effects of an alternative reinforcer, behavioral economic analysis of demand, and examination of subjective drug effects

Experimental and Clinical Psychopharmacology

Volumn 7, Issue 1, 1999, Pages 38-48

  Petry, Nancy M ^a,b   Bickel, Warren K ^a  

^a UNIVERSITY OF VERMONT   (United States)

^b UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUPRENORPHINE;

ADULT; ARTICLE; CLINICAL ARTICLE; DECISION MAKING; DRUG DEPENDENCE; DRUG DEPENDENCE TREATMENT; DRUG EFFECT; ECONOMIC ASPECT; HUMAN; HUMAN EXPERIMENT; MONEY; PERCEPTION; REINFORCEMENT;

ADULT; ANALGESICS, OPIOID; BEHAVIOR; BUPRENORPHINE; HUMANS; MALE; OPIOID-RELATED DISORDERS; REINFORCEMENT (PSYCHOLOGY); SELF ADMINISTRATION; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 0033016861     PISSN: 10641297     EISSN: None     Source Type: Journal    
DOI: 10.1037/1064-1297.7.1.38     Document Type: Article

References (51)

1. Allison, J. (1983). Behavioral substitutes and complements. In R. L. Mellgren (Ed.), Animal cognition and behavior (pp. 1-30). Amsterdam: North-Holland.
2. Amass, L., Bickel, W. K., Higgins, S. T., & Badger, G. (1994). Alternate-day dosing during buprenorphine treatment of opioid dependence. Life Sciences, 54, 1215-1228.
3. Ator, N. A., & Griffiths, R. R. (1993). Differential sensitivity to midazolam discriminate-stimulus effects following self-administered versus response-independent midazolam. Psychopharmacology, 110, 1-4.
4. Bickel, W. K., & Amass, L. (1995). Buprenorphine treatment of opioid dependence: A review. Experimental and Clinical Psychopharmacology, 3, 477-489.
5. Bickel, W. K., Amass, L., Higgins, S. T., Badger, G. J., & Esch, R. A. (1997). Effects of adding behavioral treatment to opioid detoxification with buprenorphine. Journal of Consulting and Clinical Psychology, 65, 803-810.
6. Bickel, W. K., & DeGrandpre, R. J. (1995). Price and alternatives: Suggestions for drug policy from psychology. The International Journal of Drug Policy, 6, 93-105.
7. Bickel, W. K., & DeGrandpre, R. J. (1996). Modeling drug abuse policy in the behavioral economics laboratory. In L. Green & J. H. Kagel (Eds.), Advances in behavioral economics (Vol. 3, pp. 69-95). Norwood, NJ: Ablex.
8. Bickel, W. K., DeGrandpre, R. J., & Higgins, S. T. (1995). The behavioral economics of concurrent drug reinforcers: A review and reanalysis of drug self-administration research. Psychopharmacology, 118, 250-259.
9. Bickel, W. K., DeGrandpre, R. J., Higgins, S. T., Hughes, J. R., & Badger, G. J. (1995). Effects of simulated employment and recreation on cigarette smoking: A behavioral economic approach. Experimental and Clinical Psychopharmacology, 3, 467-476.
10. Bickel, W. K., Petry, N. M., & Tzanis, E. (1997). The limits of alternate day buprenorphine dosing? In L. S. Harris (Ed.), Problems of drug dependence, 1996 (National Institute of Drug Abuse Research Monograph No. 174, DHHS Publication No. NIH 97-4236, p. 141). Washington, DC: U.S. Government Printing Office.
11. Bickel, W. K., Stitzer, M. L., Bigelow, G. E., Liebson, I. A., Jasinski, D., & Johnson, R. (1988a). Buprenorphine: Dose-related blockade of opioid challenge effects in opioid dependent humans. Journal of Pharmacology and Experimental Therapeutics, 247, 47-53.
12. Bickel, W. K., Stitzer, M. L., Bigelow, G. E., Liebson, I. A., Jasinski, D. R., & Johnson, R. E. (1988b). A clinical trial of buprenorphine: Comparison with methadone in the detoxification of heroin addicts. Clinical Pharmacology and Therapeutics, 43, 72-78.
13. Brown, G. F., & Silverman, L. P. (1974). The retail price of heroin: Estimation and applications. Journal of the American Statistical Association, 69, 595-606.
14. Carroll, M. E. (1987). Self-administration of orally delivered phencyclidine and ethanol under concurrent fixed-ratio schedules in rhesus monkeys. Psychophannacology, 93, 1-7.
15. Carroll, M. E., Lac, S. T., & Nygaard, S. L. (1989). A concurrently available non-drug reinforcer prevents the acquisition or decreases the maintenance of cocaine-reinforced behavior. Psychopharmacology, 97, 23-29.
16. DeGrandpre, R. J., & Bickel, W. K. (1996). Drug dependence as consumer demand. In L. Green & J. Kagel (Eds.), Advances in behavioral economics (Vol. 3, pp. 1-36). Norwood, NJ: Ablex.
17. DeGrandpre, R. J., Bickel, W. K. Higgins, S. T., & Hughes, J. R. (1994). A behavioral economic analysis of concurrently available money and cigarettes. Journal of the Experimental Analysis of Behavior, 61, 191-201.
18. Dworkin, S., Mirkis, S., & Smith, J. (1995). Response-dependent versus response-independent presentation of cocaine: Differences in the lethal effects of the drug. Psychopharmacology, 117, 262-266.
19. Goldberg, S. R., Hoffeister, R, Shlichting, U. U., & Wuttke, W. (1971). A comparison of pentobarbital and cocaine self administration in rhesus monkeys: Effect of dose and fixed ratio parameter. Journal of Pharmacology and Experimental Therapeutics, 179, 277-283.
20. Herrnstein, R. J., & Prelec, D. (1992). A theory of addiction. In G. Loewenstein & J. Elster (Eds.), Choice over time (pp. 331-360). New York: Russell Sage.
21. Higgins, S. T., Bickel, W. K., & Hughes, J. (1994). Influence of an alternative reinforcer on human cocaine self-administration. Life Sciences, 55, 179-188.
22. Higgins, S. T., Budney, A. J., & Bickel, W. K. (1994). Applying behavioral concepts and principles to the treatment of cocaine dependence. Drug and Alcohol Dependence, 34, 87-97.
23. Higgins, S. T., Budney, A. J., Bickel, W. K., Foerg, F. E., Donham, R., & Badger, G. J. (1994). Incentives improve outcome in outpatient behavioral treatment of cocaine dependence. Archives of General Psychiatry, 51, 568-576.
24. Higgins, S. T., Roll, J., & Bickel, W. K. (1996). Alcohol pretreatment increases preference for cocaine over monetary reinforcement. Psychopharmacology, 123, 1-8.
25. Hursh, S. R. (1980). Economic concepts for the analysis of behavior. Journal of the Experimental Analysis of Behavior, 34, 219-238.
26. Hursh, S. R. (1991). Behavioral economics of drug self-administration and drug abuse policy. Journal of the Experimental Analysis of Behavior, 56, 377-393.
27. Hursh, S. R. (1993). Behavioral economics of drug self-administration: An Introduction. Drug and Alcohol Dependence, 33, 165-172.
28. Jasinski, D. R., Pevnick, J., & Griffith, J. (1978). Human pharmacology and abuse potential of the analgesic buprenorphine: A potential agent for treating narcotic addiction. Archives of General Psychiatry, 35, 501-516.
29. Johnson, R. E., Jaffe, J. H., & Fudala, P. J. (1992). A controlled trial of buprenorphine treatment for opioid dependence. Journal of the American Medical Association, 267, 2750-2755.
30. Jones, B. E., & Prada, J. A. (1975). Drug seeking behavior during methadone maintenance. Psychopharmacologia, 41, 7-10.
31. Kosten, T. R., Shottenfeld, R., Ziedonis, D., & Falcioni, J. (1993). Buprenorphine versus methadone maintenance for opioid dependence. Journal of Nervous and Mental Disease, 181, 358-364.
32. Lamb, R. J., Preston, K. L., Schindler, C. W., Meisch, R. A., Davis, F., Katz, J. L., Henningfield, J. E., & Goldberg, S. R. (1991). The reinforcing and subjective effects of morphine in post-addicts: A dose-response study. Journal of Pharmacology and Experimental Therapeutics, 259, 1165-1173.
33. Ling, W., Wesson, D. R., Charuvastra, C., & Klett, J. (1996). A controlled trial comparing buprenorphine and methadone maintenance in opioid dependence. Archives of General Psychiatry, 53, 401-407.
34. Lukas, S. E., Griffiths, R. R., & Brady, J. V. (1983). Buprenorphine self-administration by the baboon: Comparison with other opioids. In L. Harris (Ed.), Problems of drug dependence, 1982 (National Institute on Drug Abuse Monograph No. 43, pp. 178-183). Washington, DC: U.S. Government Printing Office.
35. Mello, N. K., Bree, M. P., & Mendelson, J. H. (1981). Buprenorphine self-administration by rhesus monkeys. Pharmacology Biochemistry and Behavior, 15, 215-225.
36. Mello, N. K., Bree, M. P., & Mendelson, J. H. (1983). Comparison of buprenorphine and methadone effects on opiate self-administration in primates. Journal of Pharmacology and Experimental Therapeutics, 225, 378-386.
37. Meyer, R. E., & Mirin, S. M. (1979). The heroin stimulus. New York: Plenum.
38. Nader, M. A., & Woolverton, W. L. (1991). Effects of increasing the magnitude of an alternative reinforcer on drug choice in a discrete-trials choice procedure. Psychopharmacology, 105, 169-174.
39. Petry, N. M., & Bickel, W. K. (1998). Polydrug abuse in heroin addicts: A behavioral economic analysis. Addiction, 93, 321-335.
40. Petry, N. M., Bickel, W. K., & Tzanis, E. (1997). Quadruple buprenorphine doses maintain opioid-dependent outpatients for 96 hours with minimal withdrawal. In L. S. Harris (Ed.), Problems of drug dependence, 1996 (National Institute of Drug Abuse Research Monograph No. 174, DHHS Publication No. NIH 97-1236, p. 142). Washington, DC: U.S. Government Printing Office.
41. Petry, N. M., & Heyman, G. M. (1995). Behavioral economic analysis of concurrent ethanol/sucrose and sucrose reinforcement in the rat: Effects of altering variable-ratio requirements. Journal of the Experimental Analysis of Behavior, 64, 331-359.
42. Samson, H. H., Roehrs, T., & Tolliver, G. (1982). Ethanol-reinforced responding in the rat. A concurrent analysis using sucrose as the alternative choice. Pharmacology Biochemistry and Behavior, 77, 333-339.
43. Samuelson, P., & Nordhaus, W. D. (1985). Economics (12th ed.). New York: McGraw-Hill.
44. Schuster, C. R., Fischman, M. W., & Johanson, C. E. (1981). Internal stimulus control and subjective effects of drugs. In T. Thompson & C. E. Johanson (Eds.), Behavioral pharmacology of human drug dependence (National Institute on Drug Abuse Research Monograph No. 37, pp. 116-129). Rockville, MD: U.S. Department of Health and Human Services.
45. Seigel, S. (1988). Drug anticipation and drug tolerance. In M. Lader (Ed.), The psychopharmacology of addiction (pp. 73-96). New York: Oxford University Press.
46. Silverman, L. P., & Spruill, N. L. (1977). Urban crime and the price of heroin. Journal of Urban Economics, 4, 80-103.
47. Stitzer, M. L., McCaul, M. E., Bigelow, G. E., & Liebson, I. A. (1983). Oral methadone self-administration: Effects of dose and alternative reinforcers. Clinical Pharmacology and Therapeutics, 34, 29-35.
48. van Ours, J. C. (1995). The price elasticity of hard drugs: The case of opium in the Dutch East Indies, 1923-1938. Journal of Political Economy, 103, 261-279.
49. Walsh, S. L., Preston, K. L., Stitzer, M. L., Cone, E. J., & Bigelow, G. E. (1994). Clinical pharmacology of buprenorphine: Ceiling effects at high doses. Clinical Pharmacology and Therapeutics, 55, 569-580.
50. Winger, G., Skjoldager, P., & Woods, J. H. (1992). Effects of buprenorphine and other opioid agonists and antagonists on alfentanil- and cocaine-reinforced responding in rhesus monkeys. Journal of Pharmacology and Experimental Therapeutics, 261, 311-317.
51. Zacny, J. P., Conley, K., & Galinkin, J. (1997). Comparing the subjective, psychomotor, and physiological effects of intravenous buprenorphine and morphine in healthy volunteers. Journal of Pharmacology and Experimental Therapeutics, 282, 1187-1197.